These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Open questions on the prevention of urinary calculi recurrence]. Zechner O Z Urol Nephrol; 1981 May; 74(5):401-5. PubMed ID: 7023101 [No Abstract] [Full Text] [Related]
25. [Urolithiasis and oxalate metabolism]. Ito H Nihon Hinyokika Gakkai Zasshi; 1997 Aug; 88(8):701-11. PubMed ID: 9293746 [No Abstract] [Full Text] [Related]
26. [Clinical study of the patients with uric acid stone]. Takeuchi M; Sonoda T; Okawa T; Okuda N Hinyokika Kiyo; 1971 Jul; 17(7):483-7. PubMed ID: 5106901 [No Abstract] [Full Text] [Related]
27. [Nutrition and calcium kidney lithiasis]. Ulmann A Ann Nutr Aliment; 1980; 34(3):519-26. PubMed ID: 7469260 [No Abstract] [Full Text] [Related]
28. [To what extent does a diet varying in calcium influence recurrent lithiasis in idiopathic hypercalciuria?]. Peña JC Rev Invest Clin; 2002; 54(2):105-7. PubMed ID: 12053806 [No Abstract] [Full Text] [Related]
29. [Results of dietary evaluation during calcium oxalate and calcium phosphate lithiasis]. Mahe JL; Cledes J; Bigot JC; Bardou LG; Morel MA Nephrologie; 1993; 14(6):291-7. PubMed ID: 8145888 [TBL] [Abstract][Full Text] [Related]
30. Organic matrix of human urinary concretions. Boyce WH Am J Med; 1968 Nov; 45(5):673-83. PubMed ID: 5687257 [No Abstract] [Full Text] [Related]
31. A survey of calcium urolithiasis in normocalcemic hypercalciuria: possible role of nutrients and diet-mediated factors. Schwille PO Urol Res; 1979 Sep; 7(3):149-55. PubMed ID: 388796 [TBL] [Abstract][Full Text] [Related]
32. [Calcium oxalate calculus: therapy and prevention]. Lutzeyer W Dtsch Med Wochenschr; 1969 Jan; 94(3):141. PubMed ID: 5782577 [No Abstract] [Full Text] [Related]
33. Supersaturation and renal precipitation: the key to stone formation? Kavanagh JP Urol Res; 2006 Apr; 34(2):81-5. PubMed ID: 16437224 [No Abstract] [Full Text] [Related]
34. [New views on the therapy of urolithiasis]. Bianchi F Helv Chir Acta; 1971 Dec; 38(5):491-3. PubMed ID: 5152159 [No Abstract] [Full Text] [Related]
35. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507 [TBL] [Abstract][Full Text] [Related]
36. [Study of the auto-antibodies in phospho-calcic renal calculi]. KEUTEL HJ Rein Foie; 1962 Jun; 4():II/175-8. PubMed ID: 14455452 [No Abstract] [Full Text] [Related]
37. Microbial degradation of dietary oxalate in the human gut and urinary oxalate concentrations in patients with calcium oxalate urolithiasis and control persons. Kleinschmidt K; Mahlmann A; Hautmann R Investig Urol (Berl); 1994; 5():222-4. PubMed ID: 7719310 [No Abstract] [Full Text] [Related]
38. Metabolic and clinical disturbances in patients with calcium urolithiasis. Smith LH; Werness PG; Wilson DM Scand J Urol Nephrol Suppl; 1980; 53():213-20. PubMed ID: 6937998 [No Abstract] [Full Text] [Related]
39. [Drug therapy in urinary calculi. II. Peroral litholysis and prevention]. Terhorst B; Melchior H Urol Int; 1972; 27(3):230-44. PubMed ID: 5050852 [No Abstract] [Full Text] [Related]
40. Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones. Osther PJ; Grenabo L; Haraldsson G; Holmberg G; Lindell O; Mogensen P; Schultz A; Ulvik NM Scand J Urol Nephrol; 1999 Dec; 33(6):372-81. PubMed ID: 10636576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]